ArticleMolecular psychiatry2023

Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala.

Xu Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.